Transplantable dopamine neurons produced from stem cells could expedite treatment options for Parkinson's disease.
A new study reports neural connectivity problems associated with neurodegenerative diseases could be the result of dendritic structural degeneration.
Researchers detail the complex interaction between alpha synuclein and the prion protein PrPc.
Vitamin D supplementation may help reduce some of the non-motor symptoms associated with Parkinson's disease.
Scientists show that SR-3306 delivered orally to mice and rat models of Parkinson's disease was able to protect brain cells from neurodegeneration. SR-3306 inhibits the c-jun-N-terminal kinases (JNK) class of enzymes, previously shown to play large roles in neuron survival.
Researchers have developed a new deep brain stimulation device that is able to use feedback from the brain to fine tune its signal. The device could help those with Parkinson's disease.
People who suffer from a neurological or mental health condition are at increased risk of developing another disorder later in life. Parkinson's disease patients are four times more likely to develop dementia, and those with mental health disorders were also at greater risk of developing dementia later in life.
PINK1, a gene associated with Parkinson's disease, is not just responsible for the premature death of dopaminergic neurons, it also plays a key role in the neurogenesis of dopamine neurons throughout life.
Researchers have successfully recorded brain signatures of movement symptoms and deep brain stimulation of Parkinson's patients in real time. The findings could lay the groundwork for personalize therapies for those with the neurodegenerative disease.
People with bipolar disorder have higher incidences of Parkinson's disease than those without the psychiatric condition. Manic and depressive episodes were associated with an elevated risk of developing Parkinson's disease.